OKYO
- OKYO Pharma Limited
()
Overview
Company Summary
OKYO Pharma Limited (OKYO) is a biotechnology company that focuses on the development of novel drugs to target and treat various medical conditions. The company is primarily involved in the research and development of innovative therapeutics, with a particular emphasis on working in collaboration with academic institutions and other organizations.
OKYO Pharma specializes in identifying and acquiring promising drug candidates and potential therapies. This includes identifying compounds with promising therapeutic effects, conducting preclinical and clinical studies to assess their safety and efficacy, and ultimately bringing these potential treatments to market.
The company's research and development activities primarily focus on areas such as oncology, ophthalmology, and infectious diseases. They strive to address unmet medical needs by developing drugs that can improve patient outcomes and quality of life.
OKYO Pharma leverages cutting-edge scientific knowledge and technologies to develop proprietary drug candidates and to collaborate with partners for joint product development. They also explore licensing and other partnership opportunities that can facilitate the advancement of their drug portfolio.
Overall, OKYO Pharma Limited aims to contribute to the development of effective and innovative treatments for various diseases and medical conditions through their research, development, and collaboration efforts.